KINEPOLIS (KIN.BR) Stock Fundamental Analysis

EBR:KIN • BE0974274061

27.25 EUR
+0.35 (+1.3%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to KIN. KIN was compared to 49 industry peers in the Entertainment industry. KIN has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on KIN.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • KIN had positive earnings in the past year.
  • In the past year KIN had a positive cash flow from operations.
  • KIN had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years KIN had a positive operating cash flow.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • With a decent Return On Assets value of 3.99%, KIN is doing good in the industry, outperforming 68.89% of the companies in the same industry.
  • The Return On Equity of KIN (19.38%) is better than 77.78% of its industry peers.
  • The Return On Invested Capital of KIN (9.92%) is better than 80.00% of its industry peers.
Industry RankSector Rank
ROA 3.99%
ROE 19.38%
ROIC 9.92%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • KIN has a better Profit Margin (5.45%) than 73.33% of its industry peers.
  • In the last couple of years the Profit Margin of KIN has grown nicely.
  • With a decent Operating Margin value of 12.02%, KIN is doing good in the industry, outperforming 73.33% of the companies in the same industry.
  • KIN's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 21.80%, KIN is doing worse than 86.67% of the companies in the same industry.
  • KIN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.02%
PM (TTM) 5.45%
GM 21.8%
OM growth 3Y1.62%
OM growth 5YN/A
PM growth 3Y6.79%
PM growth 5YN/A
GM growth 3Y0.47%
GM growth 5YN/A
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KIN is still creating some value.
  • There is no outstanding debt for KIN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • KIN has an Altman-Z score of 1.61. This is a bad value and indicates that KIN is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.61, KIN is in the better half of the industry, outperforming 64.44% of the companies in the same industry.
  • The Debt to FCF ratio of KIN is 7.85, which is on the high side as it means it would take KIN, 7.85 years of fcf income to pay off all of its debts.
  • KIN has a Debt to FCF ratio (7.85) which is in line with its industry peers.
  • A Debt/Equity ratio of 2.10 is on the high side and indicates that KIN has dependencies on debt financing.
  • KIN has a Debt to Equity ratio of 2.10. This is in the lower half of the industry: KIN underperforms 64.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 7.85
Altman-Z 1.61
ROIC/WACC1.69
WACC5.87%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • KIN has a Current Ratio of 0.55. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.55, KIN is doing worse than 71.11% of the companies in the same industry.
  • KIN has a Quick Ratio of 0.55. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of KIN (0.53) is worse than 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.53
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 13.95% over the past year.
  • Measured over the past years, KIN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.02% on average per year.
  • Looking at the last year, KIN shows a very strong growth in Revenue. The Revenue has grown by 42.30%.
  • The Revenue has been growing by 26.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)13.95%
EPS 3Y12.02%
EPS 5YN/A
EPS Q2Q%-2.81%
Revenue 1Y (TTM)42.3%
Revenue growth 3Y4.16%
Revenue growth 5Y26.23%
Sales Q2Q%68.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.31% on average over the next years. This is quite good.
  • Based on estimates for the next years, KIN will show a small growth in Revenue. The Revenue will grow by 5.41% on average per year.
EPS Next Y31.97%
EPS Next 2Y21.74%
EPS Next 3Y13.31%
EPS Next 5YN/A
Revenue Next Year21%
Revenue Next 2Y13.2%
Revenue Next 3Y13.48%
Revenue Next 5Y5.41%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.32, KIN is valued correctly.
  • Based on the Price/Earnings ratio, KIN is valued cheaper than 88.89% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.07. KIN is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 10.27, the valuation of KIN can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, KIN is valued cheaper than 82.22% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of KIN to the average of the S&P500 Index (28.05), we can say KIN is valued rather cheaply.
Industry RankSector Rank
PE 16.32
Fwd PE 10.27
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, KIN is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, KIN is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.87
EV/EBITDA 7.46
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • KIN has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as KIN's earnings are expected to grow with 13.31% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y21.74%
EPS Next 3Y13.31%

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.69%, KIN has a reasonable but not impressive dividend return.
  • KIN's Dividend Yield is a higher than the industry average which is at 1.06.
  • Compared to an average S&P500 Dividend Yield of 1.82, KIN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.69%

5.2 History

  • The dividend of KIN decreases each year by -3.24%.
Dividend Growth(5Y)-3.24%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 32.78% of the earnings are spent on dividend by KIN. This is a low number and sustainable payout ratio.
DP32.78%
EPS Next 2Y21.74%
EPS Next 3Y13.31%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (2/27/2026, 7:00:00 PM)

27.25

+0.35 (+1.3%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-20
Earnings (Next)N/A
Inst Owners17.67%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap745.83M
Revenue(TTM)822.78M
Net Income(TTM)44.88M
Analysts86
Price Target45.78 (68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.69%
Yearly Dividend0.55
Dividend Growth(5Y)-3.24%
DP32.78%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.14%
PT rev (3m)-7.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)3.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.06%
Revenue NY rev (3m)9.65%
Valuation
Industry RankSector Rank
PE 16.32
Fwd PE 10.27
P/S 0.91
P/FCF 7.87
P/OCF 5.38
P/B 3.22
P/tB 14.11
EV/EBITDA 7.46
EPS(TTM)1.67
EY6.13%
EPS(NY)2.65
Fwd EY9.74%
FCF(TTM)3.46
FCFY12.71%
OCF(TTM)5.07
OCFY18.59%
SpS30.06
BVpS8.46
TBVpS1.93
PEG (NY)0.51
PEG (5Y)N/A
Graham Number17.83
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 19.38%
ROCE 13.36%
ROIC 9.92%
ROICexc 12.41%
ROICexgc 17.78%
OM 12.02%
PM (TTM) 5.45%
GM 21.8%
FCFM 11.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.62%
OM growth 5YN/A
PM growth 3Y6.79%
PM growth 5YN/A
GM growth 3Y0.47%
GM growth 5YN/A
F-Score7
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 7.85
Debt/EBITDA 2.71
Cap/Depr 54.31%
Cap/Sales 5.34%
Interest Coverage 4.68
Cash Conversion 77.15%
Profit Quality 211.16%
Current Ratio 0.55
Quick Ratio 0.53
Altman-Z 1.61
F-Score7
WACC5.87%
ROIC/WACC1.69
Cap/Depr(3y)49.94%
Cap/Depr(5y)40.94%
Cap/Sales(3y)7.03%
Cap/Sales(5y)6.61%
Profit Quality(3y)253.44%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.95%
EPS 3Y12.02%
EPS 5YN/A
EPS Q2Q%-2.81%
EPS Next Y31.97%
EPS Next 2Y21.74%
EPS Next 3Y13.31%
EPS Next 5YN/A
Revenue 1Y (TTM)42.3%
Revenue growth 3Y4.16%
Revenue growth 5Y26.23%
Sales Q2Q%68.42%
Revenue Next Year21%
Revenue Next 2Y13.2%
Revenue Next 3Y13.48%
Revenue Next 5Y5.41%
EBIT growth 1Y20.48%
EBIT growth 3Y5.85%
EBIT growth 5YN/A
EBIT Next Year129.3%
EBIT Next 3Y39.36%
EBIT Next 5Y22.96%
FCF growth 1Y-21.7%
FCF growth 3Y-4.34%
FCF growth 5YN/A
OCF growth 1Y-15.27%
OCF growth 3Y0.65%
OCF growth 5YN/A

KINEPOLIS / KIN.BR FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 5 / 10 to KIN.BR.


Can you provide the valuation status for KINEPOLIS?

ChartMill assigns a valuation rating of 8 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


What is the profitability of KIN stock?

KINEPOLIS (KIN.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of KINEPOLIS (KIN.BR) stock?

The Price/Earnings (PE) ratio for KINEPOLIS (KIN.BR) is 16.32 and the Price/Book (PB) ratio is 3.22.


Is the dividend of KINEPOLIS sustainable?

The dividend rating of KINEPOLIS (KIN.BR) is 4 / 10 and the dividend payout ratio is 32.78%.